Tag: Neurostimulation

Magnus Medical Launches with Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing

sarah JonasResearch Results

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.